These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 131710)

  • 1. Demonstration of a platelet enzyme, degrading heparan sulphate.
    Wasteson A; Höök M; Westermark B
    FEBS Lett; 1976 Apr; 64(1):218-21. PubMed ID: 131710
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a platelet endoglycosidase on cell surface associated heparan sulphate of human culturei endothelial and glial cells.
    Wasteson A; Glimelius B; Busch C; Westermark H; Heldin CH; Norling B
    Thromb Res; 1977 Sep; 11(3):309-21. PubMed ID: 144331
    [No Abstract]   [Full Text] [Related]  

  • 3. Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate.
    Sewell RF; Brenchley PE; Mallick NP
    Biochem J; 1989 Dec; 264(3):777-83. PubMed ID: 2533499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelet heparanase: purification, characterization and catalytic activity.
    Freeman C; Parish CR
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1341-50. PubMed ID: 9494105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix heparan sulphate, but not endothelial cell surface heparan sulphate, is degraded by highly metastatic mouse lymphoma cells.
    Hennes R; Frantzen F; Keller R; Schirrmacher V; Schwartz-Albiez R
    Br J Cancer; 1988 Aug; 58(2):186-8. PubMed ID: 2971387
    [No Abstract]   [Full Text] [Related]  

  • 6. A heparan sulfate-degrading endoglycosidase from rat liver tissue.
    Höök M; Wasteson A; Oldberg A
    Biochem Biophys Res Commun; 1975 Dec; 67(4):1422-8. PubMed ID: 1035
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparan sulphate-degrading endoglycosidase in liver plasma membranes.
    Gallagher JT; Walker A; Lyon M; Evans WH
    Biochem J; 1988 Mar; 250(3):719-26. PubMed ID: 3390139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate degradation in tumor cell invasion and angiogenesis.
    Vlodavsky I; Eldor A; Bar-Ner M; Fridman R; Cohen IR; Klagsbrun M
    Adv Exp Med Biol; 1988; 233():201-10. PubMed ID: 2464906
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of platelet heparanase during inflammation: role of pH and proteinases.
    Ihrcke NS; Parker W; Reissner KJ; Platt JL
    J Cell Physiol; 1998 Jun; 175(3):255-67. PubMed ID: 9572470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for degradation of heparan sulfate by endoglycosidases: glucosamine and hexuronic acid are reducing terminals of intracellular heparan sulfate from human skin fibroblasts.
    Klein U; Kresse H; von Figura K
    Biochem Biophys Res Commun; 1976 Mar; 69(1):158-66. PubMed ID: 130905
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of sulfated glycosaminoglycans in rat hepatocytes. Synthesis of heparan sulfate and distribution into cellular and extracellular pools.
    Prinz R; Klein U; Sudhakaran PR; Sinn W; Ullrich K; von Figura K
    Biochim Biophys Acta; 1980 Jul; 630(3):402-13. PubMed ID: 6446940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides.
    Oldberg A; Heldin CH; Wasteson A; Busch C; Höök M
    Biochemistry; 1980 Dec; 19(25):5755-62. PubMed ID: 7459342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactosaminoglycans and heparan sulfate are covalently bound to fibronectins synthesized by mouse stem teratocarcinoma cells.
    Cossu G; Warren L
    J Biol Chem; 1983 May; 258(9):5603-7. PubMed ID: 6222054
    [No Abstract]   [Full Text] [Related]  

  • 14. Covalent binding of lactosaminoglycans and heparan sulphate to fibronectin synthesized by a human teratocarcinoma cell line.
    Cossu G; Andrews PW; Warren L
    Biochem Biophys Res Commun; 1983 Mar; 111(3):952-7. PubMed ID: 6220715
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in the distribution of O-sulphate groups of cell-surface and secreted heparan sulphate produced by human neuroblastoma cells in culture.
    Hampson IN; Kumar S; Gallagher JT
    Biochim Biophys Acta; 1983 Sep; 763(2):183-90. PubMed ID: 6225467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-polymeric glycosaminoglycans in transformed cells. Transformation-dependent changes in the co-polymeric structure of heparan sulphate.
    Fransson LA; Havsmark B; Chiarugi VP
    Biochem J; 1982 Jan; 201(1):233-40. PubMed ID: 6282259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human vascular endothelial cells catabolise exogenous glycosaminoglycans by a novel route.
    Dawes J; Pepper DS
    Thromb Haemost; 1992 Apr; 67(4):468-72. PubMed ID: 1378652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines.
    Nakajima M; Irimura T; Di Ferrante D; Di Ferrante N; Nicolson GL
    Science; 1983 May; 220(4597):611-3. PubMed ID: 6220468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycan-degrading enzymes in the varicose vein wall.
    Kowalewski R; Sobolewski K; Malkowski A; Gacko M; Rutkowska I
    Int Angiol; 2008 Dec; 27(6):529-35. PubMed ID: 19078917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced sulfation of liver heparan sulfate in experimentally diabetic rats.
    Kjellén L; Bielefeld D; Hook M
    Diabetes; 1983 Apr; 32(4):337-42. PubMed ID: 6219905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.